186 Infos zu Joern Aldag

71 Aktuelle Nachrichten

Für klinische Studien an Immuntherapie gegen Krebs und Infektionskrankheiten.

European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology

Joern Aldag, chief executive of Amsterdam-based uniQure, said more such treatments would follow and argued a high price was justified ...

* Christian Zahnd, CEO, will temporarily be absent from the company due to a medical treatment

6 Profile in Sozialen Netzwerken

Curated profile of Joern Aldag, CEO, Hookipa Biotech including career history, news and intelligence, portfolio companies and investments.

Joern Aldag leads the amazing Hookipa Biotech team as Chief Executive Officer. Before joining Hookipa in June 2016, Joern was CEO of NASDAQ-listed uniQure ...

5 Hobbys & Interessen

... have achieved an important milestone advancing HB-201 into clinical development," Chief Executive Joern Aldag said in the announcement.

Joern Aldag, Chief Executive Officer of Hookipa said: “Our vision is of a world in which the immune system actively controls infectious diseases ...

· Thank you. Joining me today our Chief Executive Officer, Joern Aldag; Chief Financial Officer, Reinhard Kandera; Chief Medical Officer and Head ...

Joern Aldag, Chief Executive Officer of HOOKIPA said: “We are pleased that this outstanding group of new and current investors supported this ...

1 Firmen-Beteiligungen

Joern Aldag steht mit folgenden Firmen in Beziehung. Es gibt derzeit 2 Unternehmen in der Firmendatenbank, mit denen Joern Aldag in Beziehung steht. Bei der Art der Beziehung kann es sich beispielsweise um eine Position als Manager, Geschäftsführer oder Gesellschafter handeln.

3 Business-Profile

Joern Aldag is currently Chief Executive Officer at Hookipa Pharma. Joern Aldag has studied at Harvard University and at EBS University of Business and Law.

Andy Hwang ist derzeit Vice President, Clinical Operations bei Hookipa Pharma. Bei Hookipa Pharma hat Andy Hwang 22 Kollegen einschließlich Joern Aldag (CEO), Graziano Seghezzi (Director), ...

Das Organigramm von Hookipa Pharma zeigt 22 Führungskräfte, einschließlich einschließlich Joern Aldag, Reinhard Kandera, Christine Baker und Matthew Beck

4 Bücher zum Namen

Explore some of Joern Aldag best quotations and sayings on Quotes.net -- such as 'Gene therapy may be an initial very high burden for the healthcare system,...

Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of biotechnology, genetics, proteomics and related...

A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world...

Joern Aldag, CEO Joern Aldag, Pres. DirkH. Ehlers, CFO Martyn Melvin, Dir.-Human Resources Erich Greiner, Exec. VP-Science Tim Tasker, Exec.

1 Dokumente

Joern Aldag has served as our Chief Executive Officer since June and as a member of our Board of Directors since June Mr. Aldag served as the.

1 Wissenschaftliche Publikationen

— ... seeing the potential impact of our novel arenaviral platform as a component of care," Joern Aldag, CEO of Hookipa, said in a statement.

4 Meinungen & Artikel

— ... science into the differentiated, versatile platform technology it is today” commented CEO Joern Aldag #appointment #Immunotherapy.

... of Europe's largest biotechs and launched the first approved gene therapy in Europe. Joern Aldag, now CEO at Austrian biotech Hookipa Pharma, has done both.Missing: Kampen (Sylt)" ... of Europe's largest biotechs and launched the first approved gene therapy in Europe. Joern Aldag, now CEO at Austrian biotech Hookipa Pharma, has done both. Missing: Kampen (Sylt)"

— Christoph Lengauer, Julie O'Neill, Graziano Seghezzi, Joern Aldag, and Reinhard Kandera. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a ...

Ray Hill (Merck Sharpe & Dohme, UK), Paul McCubbin (BTG, UK), Mark Kessel (Symphony Capital, USA) and Joern Aldag (Evotec AG, ...

88 Webfunde aus dem Netz

Mr. Joern Aldag, CEO & Director, 549,34k, N/A, Dr. Reinhard Kandera Ph.D. CFO & Director, 468,31k, N/A, Ms. Christine D. Baker M.B.A — Participants. Joern Aldag; CEO; Hookipa Pharma Inc. Reinhard Kandera; CFO; Hookipa Pharma Inc. Katia Schlienger; Chief Medical Officer; ...

Mr. Joern Aldag, CEO & Director, k, N/A, Dr. Reinhard Kandera, CFO & Director, k, N/A, Dr. Igor Matushansky M.D., Ph.D.

Joern Aldag. Nov. 02, 2012News & Opinions Europe Approves High-Price Gene Therapy European officials have approved the Western world's first gene therapy drug...

Name, Title, Pay, Exercised, Year Born. Mr. Joern Aldag, Pres, CEO & Director, k, N/A, Dr. Reinhard Kandera, CFO & Director, k, N/A,

As Chief Executive Officer at HOOKIPA PHARMA INC, Joern Aldag made $2,605,450 in total compensation. Of this total $572,334 was received as a salary, $243,

On Professor Lambert's departure, HOOKIPA's CEO Joern Aldag commented: “I wish to thank Paul-Henri for his commitment to the Company as ...

Joern Aldag is the Pres, CEO & Director at HOOKIPA Pharma.

... activation therapies for oncology and infectious diseases, today announced that CEO Joern Aldag will be presenting at the 36th Annual J.P..

Joern Aldag UniQure. Nov. 02, 2012News & Opinions Europe Approves High-Price Gene Therapy European officials have approved the Western world's first gene...

 Joern Aldag leads the amazing Hookipa Biotech team as Chief Executive Officer. Before joining Hookipa in June 2016, Joern was CEO of NASDAQ-listed uniQure...

Joern Aldag stated : “In the second quarter of 2019, HOOKIPA achieved a number of major milestones, including clearance to initiate our first clinical trial in ...

Joern Aldag Resigns as CEO of Evotec AG - read this article along with other careers information, tips and advice on BioSpace

At the meeting, Joern Aldag (President & CEO), Dr Dirk Ehlers (CFO) and Dr John Kemp (CEO of ENS) will present further details of the

Auf Nachfrage der PZ teilte Joern Aldag, CEO bei Uniqure, mit, dass der Preis für die Behandlung mit Glybera bisher nicht bekannt sei, da noch mit keinem Land die Kostenerstattung verhandelt wurde. »Wir wissen aus einer Marktforschungsrecherche, dass Kassen in Europa generell bereit sind, die Kosten einer vergleichbaren Behandlung im Bereich ...

About. Download (Excel). CEO. Mr. Joern Aldag. Sector. Healthcare. Industry.

... antigen-specific CD8+ T cells–to overcome the limitations of checkpoint inhibitor monotherapy,” said Joern Aldag, Chief Executive Officer at HOOKIPA.

ulbrich&partner Management Consulting is specializing in …, life science, and health care technologies. Working with a flexible team of...

Joern Aldag, Chief Executive Officer and Director. Dr. Reinhard Kandera Ph.D. Chief Financial Officer and Director. Prof. Rolf M. Zinkernagel M.D., Ph.D.

PRAWER'S CHILDREN DRAWING

... by uniQure's CEO Joern Aldag yesterday as “one of the largest and most comprehensive collaborations in the gene therapy sector to date.”​.